Work

Genetic and chemical correction of cystic fibrosis reduces airway susceptibility to SARS-CoV-2

Year: 2026
Type: article
Abstract: Using rigorously controlled iPSC-derived airway models, the study shows that CFTR-deficient cells are more vulnerable to SARS-CoV-2 and display stronger inflammation than syngeneic CFTR-corrected controls. The CFTR modulator ETI reduces viral injury and boosts antiviral pathways in both CF and non-CF cells. Even at baseline, CFTR modulation enhances antiviral responses and lowers inflammation. Overall, the findings reveal a broad protective antiviral effect of CFTR modulators and highlight their therapeutic promise in inflammatory lung disease.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7124882301
FWCI: 8.927
Cites: 79
Cited by: 2
Related to: